BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Feb 24, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-02-20

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-20	Common Stock	S	8000	$80.00	Disposed	46740	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	194520	Direct
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	20000	Indirect

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 9, 2013

F2: All shares sold at the same price.

F3: The reporting person and his spouse act as trustees for the Bienaime Family Trust.

F4: The reporting person's spouse is trustee of each child's trust.